InPharma
InPharma has the goal of eliminating animals from the development of new oral drug formulations (EU funds MSCA-H2020 EID InPharma)
Modern tools of computational pharmaceutics such as artificial intelligence/machine learning are used to guide formulation development. Several larger and smaller companies as well as universities are part of this EU project (the project homepage provides further information about this research project) and FHNW (Prof. Kuentz) is leading the formulation development work package (WP1).
Share this page: